疼痛灾难化影响青少年特发性脊柱侧凸患者术前和术后的患者报告结局
这项前瞻性队列研究纳入189例接受后路脊柱融合术的青少年特发性脊柱侧凸患者,其中20例(10.6%)存在疼痛灾难化(PCS评分≥第75百分位)。疼痛灾难化组术前所有SRS-30领域评分均显著低于PCS正常组,术后2年多数领域显著改善,但疼痛和总分仍低于PCS正常组。术前SRS-30疼痛评分<3.5对预测疼痛灾难化具有良好敏感性。
要点
- 青少年特发性脊柱侧凸患者中疼痛灾难化患病率为10.6%(20/189)。
- 疼痛灾难化组术前SRS-30各领域评分均显著低于PCS正常组,满意度除外。
- 术后2年疼痛灾难化组疼痛和总分仍低于PCS正常组,但较术前显著改善。
核心结论
- 在本队列中,存在疼痛灾难化的青少年特发性脊柱侧凸患者在后路脊柱融合术后2年自报健康状态显著改善,但未达到PCS正常组的水平。
- 疼痛灾难化可能通过较低的术前SRS-30疼痛评分被识别。
研究设计与样本
- 前瞻性队列研究,连续纳入接受后路脊柱融合术的青少年特发性脊柱侧凸患者,共189例,其中20例(10.6%)存在疼痛灾难化(PCS评分≥第75百分位),与PCS评分正常者比较。
- 证据等级为预后II级。
主要发现
- 疼痛灾难化组与PCS正常组人口学和影像学变量相当。
- 术前SRS-30评分:疼痛领域疼痛灾难化组2.98 vs PCS正常组3.95(p<0.001);外观领域2.98 vs 3.48(p<0.001);活动领域3.51 vs 4.06(p<0.001);心理健康领域3.12 vs 4.01(p<0.001);总分3.18 vs 3.84(p<0.001);满意度领域3.72 vs 3.69(p>0.999)。
- 术后2年,疼痛灾难化组疼痛领域从术前2.98改善至3.84(p<0.001),总分从3.18改善至3.85(p<0.001)。
- 术后2年,疼痛灾难化组疼痛领域3.84 vs PCS正常组4.22(p=0.028),总分3.85 vs 4.15(p=0.038),仍低于PCS正常组。
- ROC曲线分析显示,SRS-30疼痛评分<3.5对预测疼痛灾难化(PCS≥第75百分位)具有良好敏感性。
关键数值与推荐
- 疼痛灾难化定义为Pain Catastrophizing Scale for Children(PCS)评分≥第75百分位。
- SRS-30疼痛评分<3.5对预测疼痛灾难化具有良好敏感性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with adolescent idiopathic scoliosis (AIS) often report chronic back pain; however, there is inadequate research on psychological factors associated with pain in this patient population. Pain catastrophizing, a psychological factor that describes a pattern of negative thoughts and feelings about pain, has been associated with poorer responses to medical treatment for pain. The purpose of this study was to report the prevalence of pain catastrophizing in the AIS population and assess its relationship with preoperative and postoperative self-reported outcomes. METHODS: In this prospective cohort study of consecutive patients undergoing posterior spinal fusion (PSF) for AIS, patients experiencing clinically relevant pain catastrophizing, defined as a Pain Catastrophizing Scale for Children (PCS) score in the 75th percentile or higher, were compared with patients with normal PCS scores. Preoperative and 2-year postoperative Scoliosis Research Society Society Questionnaire-30 (SRS-30) scores were correlated with the preoperative PCS score. RESULTS: One hundred and eighty-nine patients underwent PSF for AIS, and 20 (10.6%) were considered to be experiencing pain catastrophizing. Despite comparable demographic and radiographic variables, pain catastrophizing was associated with significantly lower preoperative scores than were found in the normal-PCS group in all SRS-30 domains, including pain (2.98 versus 3.95; p < 0.001), appearance (2.98 versus 3.48; p < 0.001), activity (3.51 versus 4.06; p < 0.001), mental health (3.12 versus 4.01; p < 0.001), and total score (3.18 versus 3.84; p < 0.001), except satisfaction (3.72 versus 3.69; p > 0.999). At 2 years, the pain catastrophizing group experienced significant improvement from their preoperative scores in most SRS-30 domains, including a large clinically relevant improvement in pain (from 2.98 preoperatively to 3.84 postoperatively; p < 0.001) and the total score (from 3.18 to 3.85; p < 0.001), but continued to have lower scores than the normal-PCS group for pain (3.84 versus 4.22; p = 0.028) and the total score (3.85 versus 4.15; p = 0.038). Receiver operating characteristic (ROC) curve analysis indicated that an SRS-30 pain score of <3.5 has good sensitivity for predicting pain catastrophizing (PCS ≥75th percentile). CONCLUSIONS: In this cohort, patients with AIS who exhibited pain catastrophizing experienced significant improvement in self-reported health 2 years after PSF. However, they did not have the same levels of self-reported health as the normal-PCS group. Pain catastrophizing may be identifiable by lower preoperative SRS-30 pain scores. LEVEL OF EVIDENCE: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
引用
- Ramo BA, Collins-Jones TL, Thornberg D, et al. Pain Catastrophizing Influences Preoperative and Postoperative Patient-Reported Outcomes in Adolescent Idiopathic Scoliosis. J Bone Joint Surg Am. 2022. PMID: 35984014. doi:10.2106/JBJS.22.00258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。